Mediwound Ltd. current report, Q2 FY2019

Business Context and Reporting Period

This Form 6-K filing by MediWound Ltd. covers the month of June 2019, specifically dated June 11, 2019. The filing serves to disclose a corporate governance update rather than financial results.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is not a financial statement.

Material Changes

The material change disclosed in this filing is the appointment of Mr. Boaz Gur-Lavie as the Company's Chief Financial Officer.

Guidance, Outlook, and Risks

The filing contains no guidance, outlook, management commentary on operations, risks, contingencies, or unusual items. The content is limited to the executive appointment announcement.

Investor Verification Checklist

  • Verify the professional background and qualifications of the newly appointed CFO, Mr. Boaz Gur-Lavie.
  • Confirm the effective date of the appointment and any transition arrangements for the previous CFO.
  • Review the attached press release (Exhibit 99.1) for additional details on the leadership change.